Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Acceleron Pharma Inc.
DescriptionLigand trap inhibiting myostatin (MSTN; GDF8), growth differentiation factor 11 (GDF11), activin A and activin B
Molecular Target Myostatin (MSTN) (GDF8) ; Growth differentiation factor 11 (GDF11)
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard Indication Musculoskeletal (unspecified)
Indication DetailsIncrease muscle mass and strength
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today